| pubmed-article:16225752 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16225752 | lifeskim:mentions | umls-concept:C0020542 | lld:lifeskim |
| pubmed-article:16225752 | lifeskim:mentions | umls-concept:C0079284 | lld:lifeskim |
| pubmed-article:16225752 | lifeskim:mentions | umls-concept:C0596019 | lld:lifeskim |
| pubmed-article:16225752 | lifeskim:mentions | umls-concept:C1704259 | lld:lifeskim |
| pubmed-article:16225752 | lifeskim:mentions | umls-concept:C1705987 | lld:lifeskim |
| pubmed-article:16225752 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
| pubmed-article:16225752 | lifeskim:mentions | umls-concept:C0909977 | lld:lifeskim |
| pubmed-article:16225752 | lifeskim:mentions | umls-concept:C0909976 | lld:lifeskim |
| pubmed-article:16225752 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:16225752 | pubmed:dateCreated | 2005-10-17 | lld:pubmed |
| pubmed-article:16225752 | pubmed:abstractText | To elucidate the involvement of the endothelin (ET) pathway in the pathogenesis of monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) and the therapeutic effect of CPU 86017 (p-chlorobenzyltetrahydroberberine chloride) in rats. | lld:pubmed |
| pubmed-article:16225752 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16225752 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16225752 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16225752 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16225752 | pubmed:issn | 1671-4083 | lld:pubmed |
| pubmed-article:16225752 | pubmed:author | pubmed-author:SuWeiW | lld:pubmed |
| pubmed-article:16225752 | pubmed:author | pubmed-author:ZhangTian-tai... | lld:pubmed |
| pubmed-article:16225752 | pubmed:author | pubmed-author:CuiBingB | lld:pubmed |
| pubmed-article:16225752 | pubmed:author | pubmed-author:DaiDe-zaiDZ | lld:pubmed |
| pubmed-article:16225752 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16225752 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:16225752 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16225752 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16225752 | pubmed:pagination | 1309-16 | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:meshHeading | pubmed-meshheading:16225752... | lld:pubmed |
| pubmed-article:16225752 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16225752 | pubmed:articleTitle | CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway. | lld:pubmed |
| pubmed-article:16225752 | pubmed:affiliation | Research Division of Pharmacology, China Pharmaceutical University, Nanjing 210009, China. | lld:pubmed |
| pubmed-article:16225752 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16225752 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
